3 Safest Stocks to Buy Now
With the S&P 500 now in correction and stocks selling…
Buy
73
CPRX Quote, Financials, Valuation and Earnings
Last price:
$20.93
Seasonality move
:
14.72%
Day range:
$20.68 - $21.25
52-week range:
$14.47 - $24.64
Dividend yield:
0%
P/E ratio:
15.93x
P/S ratio:
5.30x
P/B ratio:
3.48x
Volume:
829.8K
Avg. volume:
1.1M
1-year change:
25.57%
Market cap:
$2.5B
Revenue:
$491.7M
EPS (TTM):
$1.31
Catalyst Pharmaceuticals Number of Institutional Trades
Catalyst Pharmaceuticals Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$4.4B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$2.7B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Catalyst Pharmaceuticals Institutional Ownership
-
What Percentage Of CPRX Is Owned by Institutions?
-- of CPRX is owned by institutions.
-
How Many Institutions Own CPRX Shares?
Catalyst Pharmaceuticals stock is owned by 656 institutional shareholders at this time.
-
Have Institutions Been Buying CPRX Stock?
Yes, institutions have bought 125.7M shares of CPRX in the last quarter.
-
Have Institutions Been Selling CPRX Stock?
Yes, institutions have sold 69.2M shares of CPRX over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Tesla Stock: The Bear Case
The recent stock market drop has been a punishing time…
Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Alerts
Sell
5
CABO alert for Mar 14
Cable One [CABO] is down 2.27% over the past day.
Sell
38
ADBE alert for Mar 14
Adobe [ADBE] is up 4.41% over the past day.
Sell
29
CAR alert for Mar 14
Avis Budget Group [CAR] is up 13.19% over the past day.
